Trump Builds $274 Million War Chest Ahead of Midterms
We Should All Be Biking Along the Beach
Seeking Relief From Heat and Smog, Cities Follow the Wind
Chicago Curbs Hiring, Travel to Tackle $1 Billion Budget Hole
NYC Mayor Adams Gives Bally's Bronx Casino Plan a Second Chance
The latest filings to the Federal Election Commission show that the fundraising haul, which includes donations to three leadership political action committees, joint fundraising committees and an allied super PAC, leaves Trump with $274 million cash on hand.
It's a massive war chest he can deploy on behalf of Republican House and Senate candidates in the midterm elections, when the incumbent president's party generally loses seats, and it highlights the continued grip Trump retains on the GOP.
Trump's super PAC, MAGA Inc., provided the biggest draw for campaign cash, taking in $177 million. The president has held four $1 million-per-plate dinners for MAGA Inc. donors as well as a $1.5 million-per-plate event for entrepreneurs and investors in cryptocurrency and artificial intelligence, two emerging technologies that have been a focus for his administration.
While the FEC disclosures don't indicate whether a donor attended an event or simply wrote a check, they do reveal support from executives in tech, finance and energy for Trump. Yass, the co-founder of trading firm Susquehanna International Group and a major shareholder in TikTok parent ByteDance Ltd, gave $16 million. Pipeline billionaire Kelcy Warren and his company, Energy Transfer LP combined to give $25 million.
Crypto industry donors poured money in as well. Foris DAX Inc., parent of exchange Crypto.com, gave $10 million, while Blockchain.com Inc. gave $5 million. Venture capitalists Marc Andreessen and Ben Horowitz each gave $3 million, while billionaire twins Tyler Winklevoss and Cameron Winklevoss combined to give just over $2 million.
MAGA Inc. got a $5 million donation from Musk, a close Trump ally who fell out with the president after leaving his role overseeing the Department of Government Efficiency in late May. Musk has criticized Trump and Republicans over their signature tax and spending bill. Musk's donation hit on June 27, the same day he gave $5 million checks to two super PACs that back Republican candidates in the House and Senate. Musk in July vowed to create a third party.
Earlier: Musk Gave His Super PAC $45.3 Million in First Half of 2025
While the money doesn't guarantee that Republicans will hold onto their narrow margins in the House and Senate, it gives them a major financial advantage over Democrats, who don't have a single leader to rally around or to spearhead fundrasing.
The Democratic National Committee has raised $69 million, while Future Forward, the party's main super PAC, recevied donations of about $1 million.
Big-Dollar Donors
While big donors continued to power Trump's fundraising — about 70% of his haul came from contributors who gave $1 million or more — his small-dollar donor support, the backbone of his political operation, slowed. He raised $22 million from contributors donating less than $200, with most of that raised by Trump National JFC, which splits donations between the Never Surrender PAC, formerly his presidential campaign committee, and the Republican National Committee.
Never Surrender and his other leadership PACs — Save America, which he's used to pay legal bills, and Make America Great Again PAC — ended June with $41 million cash on hand. The three committees combined to spend $26.5 million, with $6 million of that amount going to legal fees.
Trump is still trying to overturn his 2024 conviction on 34 felony counts for falsifying business records to cover up hush-money payments to adult-film actress Stormy Daniels. He's also fighting a judgment of civil fraud and a fine that now tops $500 million from a suit over his real estate valuations, as well as an $83.3 million award to writer E. Jean Carroll for defamation.
(Removes characterization of unpublished DNC report on 2024 election in ninth paragraph.)
How Podcast-Obsessed Tech Investors Made a New Media Industry
Everyone Loves to Hate Wind Power. Scotland Found a Way to Make It Pay Off
Russia Builds a New Web Around Kremlin's Handpicked Super App
What's Really Behind Those Rosy GDP Numbers?
Cage-Free Eggs Are Booming in the US, Despite Cost and Trump's Efforts
©2025 Bloomberg L.P.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Trump says semiconductors will face 100% tariff unless companies build in US
President Trump said that he will implement a 100% tariff on semiconductors manufactured overseas unless the companies have committed to build in the US. Trump made the announcement during a press event in the Oval Office alongside Apple (AAPL) CEO Tim Cook who was onhand to unveil an additional $100 billion investment in research and manufacturing in the US. "The good news for companies like Apple is, if you're building in the United States, or have committed to build, without question, commited to build in the United States, there will be no charge," Trump said. The semiconductor tariff is a part of the Trump administration's Section 232 national security investigation into chip manufacturing. According to Trump, if a company says it will build in the US, but doesn't, they will once again face tariffs as well as back tariffs. The tech industry has been waiting on tenterhooks to find out what semiconductor tariffs would look like, and whether they would apply to individual semiconductors or to chips built into devices. Additional tariffs could drive up the price of everything from smartphones and laptops to home electornics and more. Apple also is also expected to dodge Trump's newest tariffs on India, which could reach as much as 50% in three weeks, with a White House official saying that the company wouldn't have to deal with the bulk of the tariffs. Email Daniel Howley at dhowley@ Follow him on X/Twitter at @DanielHowley. Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
Firefly Aerospace to price US IPO as it sets sights on a positive liftoff
By Pritam Biswas and Arasu Kannagi Basil (Reuters) -Northrop Grumman-backed Firefly Aerospace, the buzzy space technology startup that put a lander on the moon, is set to price its U.S. IPO later on Wednesday. In a nascent but rapidly growing commercial space industry, Firefly's IPO has attracted investor attention because it successfully landed its uncrewed Blue Ghost spacecraft on the moon in its first attempt in March. Cedar Park, Texas-based Firefly Aerospace is set to sell 16.2 million shares of its stock, priced between $41 and $43 apiece. This range was raised earlier this week, signaling strong demand. U.S. President Donald Trump's focus on commercializing space technology and safeguarding the national interests in space has attracted venture capital firms and billionaires. Elon Musk's SpaceX — the most valuable private company in the world — has become a critical part of the U.S. satellite network, even prompting a need across the government to look for more contractors. The U.S. government is betting that diversifying its contractor base will foster innovation and cut the huge costs of sending rockets to space, as well as reduce over-reliance on a single provider for critical missions. NASA's procurement process now includes new entrants such as Firefly Aerospace and Sierra Space, alongside legacy companies, leveraging commercial partnerships for lunar landers, space station modules and cargo deliveries. While space-related IPOs have been scarce in recent years, the tide is starting to turn in 2025. Firefly's listing comes on the heels of the successful New York flotations of space and defense firms Karman, AIRO Group and Voyager. As of Tuesday's close, shares of Karman have more than doubled from their offer price, while Voyager has gained 10%. "Given Firefly and the success of Voyager, I think you are going to see several more space-related companies test the waters of a public offering," said Ross Carmel, partner at law firm Sichenzia Ross Ference Carmel. TO THE MOON Formed in 2017, Firefly designs and manufactures small- to medium-lift launch vehicles, lunar landers and orbital vehicles. It had a backlog of roughly $1.1 billion and over 30 planned launches under contract as of March 31. While Houston-based Intuitive Machines' Odysseus lander was the first private lander to reach the moon last year, it made a lopsided touchdown, landing mostly intact but dooming many of its onboard instruments. Firefly's was the second, but its Blue Ghost spacecraft landed safely, reaching the moon's surface a month and a half after launching atop a SpaceX rocket from NASA's Kennedy Space Center in Florida. Last month, Firefly secured a $176.7 million contract to deliver five NASA payloads to the Moon's South Pole in 2029. Firefly was valued at more than $2 billion in a 2024 funding round. The company's backers include aerospace-focused private investment firm AE Industrial Partners. U.S. defense contractor Northrop Grumman, which invested $50 million into Firefly to aid the production of their jointly developed rocket, is one of three suppliers of solid rocket motors (SRMs) to the United States. Firefly is expected to begin trading on the Nasdaq under the ticker symbol "FLY" on Thursday.
Yahoo
11 minutes ago
- Yahoo
Novo Nordisk Ramps Up U.S. Legal Fight Over Wegovy, Ozempic Copies
Novo Nordisk (NOVO, Financials) expanded its U.S. legal campaign against makers of unapproved versions of semaglutide the active ingredient in its blockbuster weight?loss and diabetes drugs Wegovy and Ozempic. The Danish drugmaker said Tuesday it filed 14 new lawsuits; the targets include telehealth providers, compounding pharmacies, and medical spas accused of selling compounded semaglutide under the fake guise of personalization. Warning! GuruFocus has detected 1 Warning Sign with NVO. The suits name firms such as Prism Aesthetics, Mochi Health, and Fella Health; some have also appeared in Eli Lilly's (LLY, Financials) litigation over knockoff versions of its weight?loss drug Zepbound. Novo claims the defendants are steering patients toward compounded semaglutide that has not been approved by regulators; in some cases, the products allegedly contain illicit foreign?sourced active pharmaceutical ingredients. Compounders were temporarily allowed to produce semaglutide during a declared shortage; when the U.S. Food and Drug Administration ended that allowance, some companies shifted to offering personalized versions outside the approved drug label. Novo argues the approach violates state laws on corporate practice of medicine; it also raises safety concerns, as the copies have not been proven effective. Industry groups pushed back; Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said Novo's claims misrepresent the work of legitimate, state?licensed pharmacies. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
